Clinical utility of combining the C-reactive protein-to-albumin ratio and systemic immune-inflammation index for prognostic assessment in metastatic renal cell carcinoma
Nobuhito Muramoto, Masayoshi Nagata, Hisashi Hirano, Tomoya Shirakawa, Toshiyuki China, Haruna Kawano, Shuji Isotani, Hisamitsu Ide · 2026
Read Clinical utility of combining the C-reactive protein-to-albumin ratio and systemic immune-inflammation index for prognostic assessment in metastatic renal cell carcinoma by Nobuhito Muramoto, Masayoshi Nagata, Hisashi Hirano, Tomoya Shirakawa, Toshiyuki China, Haruna Kawano, Shuji Isotani, Hisamitsu Ide (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0345724.txt.
Description
Nobuhito Muramoto and eight colleagues published this research article in PLOS ONE in 2026. It concerns metastatic renal cell carcinoma, kidney cancer that has spread. The authors assess prognosis, the likely course of the disease, using two blood-based scores combined: one built on the systemic immune-inflammation index, the other on a ratio of C-reactive protein to albumin.
Both scores are built from routine blood tests, one reflecting inflammation and nutrition, the other immune cell balance. Judging whether the pair beats either alone helps doctors sort patients by risk cheaply. Oncologists treating advanced kidney cancer are the readers who could fold such combined scores into treatment planning.
Catalog record
| CREATOR | Nobuhito Muramoto, Masayoshi Nagata, Hisashi Hirano, Tomoya Shirakawa, Toshiyuki China, Haruna Kawano, Shuji Isotani, Hisamitsu Ide |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42340 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |